Circadian Disruption, Fatigue, and Anorexia Clustering in Advanced Cancer Patients: Implications for Innovative Therapeutic Approaches
暂无分享,去创建一个
Pasquale F Innominato | F. Lévi | T. Rich | P. Innominato | M. Mormont | J. Waterhouse | Jim Waterhouse | Marie-Christine Mormont | Francis A Lévi | Tyvin A Rich | Georg A Bjarnason | G. Bjarnason
[1] J. Bower. Behavioral symptoms in patients with breast cancer and survivors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Jamie S Myers,et al. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms. , 2008, Oncology nursing forum.
[3] A. Berger,et al. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. , 2000, Oncology nursing forum.
[4] Ueli Schibler,et al. Circadian rhythms: mechanisms and therapeutic implications. , 2007, Annual review of pharmacology and toxicology.
[5] David Spiegel,et al. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? , 2003, Brain, Behavior, and Immunity.
[6] P. Stone,et al. Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: evaluation of diagnostic criteria for cancer-related fatigue. , 2006, Journal of pain and symptom management.
[7] N. Macdonald. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. , 2007, The journal of supportive oncology.
[8] P. Andrews,et al. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment , 2002, Supportive Care in Cancer.
[9] E. Voest,et al. Symptom prevalence in patients with incurable cancer: a systematic review. , 2007, Journal of pain and symptom management.
[10] Greg Atkinson,et al. Jet lag: trends and coping strategies , 2007, The Lancet.
[11] M. Mormont,et al. Contribution of the rest–activity circadian rhythm to quality of life in cancer patients , 2002, Chronobiology international.
[12] Erin L. McDearmon,et al. The genetics of mammalian circadian order and disorder: implications for physiology and disease , 2008, Nature Reviews Genetics.
[13] A. Chesson,et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. , 2007, Sleep.
[14] U. Schibler. Circadian time keeping: the daily ups and downs of genes, cells, and organisms. , 2006, Progress in brain research.
[15] P. Stone,et al. A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome , 2009, European journal of cancer.
[16] T Roenneberg,et al. Entrainment of the human circadian clock. , 2007, Cold Spring Harbor symposia on quantitative biology.
[17] E. Bruera,et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. , 2008, The Lancet. Oncology.
[18] A. Adamantidis,et al. Sleep and metabolism: shared circuits, new connections , 2008, Trends in Endocrinology & Metabolism.
[19] R. Cunningham,et al. Putting evidence into practice: evidence-based interventions to prevent and manage anorexia. , 2009, Clinical journal of oncology nursing.
[20] M. Hotopf,et al. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. , 2008, Journal of the National Cancer Institute.
[21] Kathryn A. Lee,et al. Impaired sleep and rhythms in persons with cancer. , 2004, Sleep medicine reviews.
[22] R. Foster,et al. The rhythm of rest and excess , 2005, Nature Reviews Neuroscience.
[23] E. Maywood,et al. Entrainment of the circadian system of mammals by nonphotic cues. , 1998, Chronobiology international.
[24] F. Lévi,et al. Circadian‐system alterations during cancer processes: A review , 1997, International journal of cancer.
[25] D. Skene,et al. Social influences on mammalian circadian rhythms: animal and human studies , 2004, Biological reviews of the Cambridge Philosophical Society.
[26] H. Kraemer,et al. Diurnal cortisol rhythm as a predictor of breast cancer survival. , 2000, Journal of the National Cancer Institute.
[27] Declan Walsh,et al. Symptom clustering in advanced cancer , 2006, Supportive Care in Cancer.
[28] Takeshi Sakurai,et al. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness , 2007, Nature Reviews Neuroscience.
[29] J Lellouch,et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] H. Geinitz,et al. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. , 2001, International journal of radiation oncology, biology, physics.
[31] Loki Natarajan,et al. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. , 2009, Sleep.
[32] J. Bower,et al. Cancer-related fatigue: Links with inflammation in cancer patients and survivors , 2007, Brain, Behavior, and Immunity.
[33] Clete Kushida,et al. Practice parameters for using polysomnography to evaluate insomnia: an update. , 2003, Sleep.
[34] A. B. Reddy,et al. A clockwork web: circadian timing in brain and periphery, in health and disease , 2003, Nature Reviews Neuroscience.
[35] M. Dodd,et al. Symptom clusters: the new frontier in symptom management research. , 2004, Journal of the National Cancer Institute. Monographs.
[36] M. Hertzog,et al. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy , 2009, Supportive Care in Cancer.
[37] M. Ramoni,et al. Links between regimen-related toxicities in patients being treated for colorectal cancer , 2009, Current opinion in supportive and palliative care.
[38] Kathryn A. Lee,et al. Methodological challenges when using actigraphy in research. , 2008, Journal of pain and symptom management.
[39] S. Ancoli-Israel,et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] E. Bruera,et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. , 2004, Cytokine.
[41] A. Reinberg,et al. Euchronism, Allochronism, and Dyschronism: Is Internal Desynchronization of Human Circadian Rhythms a Sign of Illness? , 2007, Chronobiology international.
[42] S. Asch,et al. Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] P. Ganz,et al. Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer , 2009, Clinical Cancer Research.
[44] C. Drake,et al. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. , 2004, Sleep.
[45] A. Berger,et al. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. , 1998, Oncology nursing forum.
[46] Circadian function in patients with advanced non-small-cell lung cancer , 2005, British Journal of Cancer.
[47] Christine Miaskowski,et al. Occurrence of symptom clusters. , 2004, Journal of the National Cancer Institute. Monographs.
[48] A. Berger,et al. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. , 1999, Oncology nursing forum.
[49] John O'Neill,et al. Circadian timing in health and disease. , 2006, Progress in brain research.
[50] Sonia Ancoli-Israel,et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer , 2006, Supportive Care in Cancer.
[51] G. Richardson,et al. Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies. , 2000, Sleep.
[52] C. McClung,et al. Circadian genes, rhythms and the biology of mood disorders. , 2007, Pharmacology & therapeutics.
[53] C. Pollak,et al. The role of actigraphy in the study of sleep and circadian rhythms. , 2003, Sleep.
[54] R. Dantzer,et al. A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms , 2004, Neuroimmunomodulation.
[55] Steven A. Brown,et al. The mammalian circadian timing system: from gene expression to physiology , 2004, Chromosoma.
[56] Kathryn A. Lee,et al. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. , 1999, Journal of pain and symptom management.
[57] G. Morrow. Cancer-related fatigue: causes, consequences, and management. , 2007, The oncologist.
[58] Elizabeth B. Klerman,et al. Clinical Aspects of Human Circadian Rhythms , 2005, Journal of biological rhythms.
[59] N. Tinari,et al. Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] C. Miaskowski. Symptom clusters: establishing the link between clinical practice and symptom management research , 2006, Supportive Care in Cancer.
[61] Steven A. Brown,et al. Peripheral Circadian Oscillators in Mammals: Time and Food , 2003, Journal of biological rhythms.
[62] M. Chiu,et al. Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. , 2006, Journal of the Formosan Medical Association = Taiwan yi zhi.
[63] D. Spiegel. Losing sleep over cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] F. Davis,et al. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters , 2005, Brain Research.
[65] S. Ancoli-Israel,et al. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer , 2005, Biological Psychology.
[66] M. Perlis,et al. Cancer-related fatigue and sleep disorders. , 2007, The oncologist.
[67] C A Czeisler,et al. Circadian timekeeping in health and disease. Part 1. Basic properties of circadian pacemakers. , 1983, The New England journal of medicine.
[68] Stefano Iacobelli,et al. Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer , 2005, Clinical Cancer Research.
[69] D. Skene,et al. Nonphotic Entrainment in Humans? , 2005, Journal of biological rhythms.
[70] C A Czeisler,et al. Circadian timekeeping in health and disease. Part 2. Clinical implications of circadian rhythmicity. , 1983, The New England journal of medicine.
[71] P. Zee,et al. Current understanding of the circadian clock and the clinical implications for neurological disorders. , 2001, Archives of neurology.
[72] M. Dodd,et al. Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. , 2007, Journal of the National Cancer Institute. Monographs.
[73] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[74] Max Hirshkowitz,et al. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. , 2003, Sleep.
[75] Sangeeta Agrawal,et al. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. , 2007, Journal of pain and symptom management.
[76] T. Rich. Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. , 2007, The journal of supportive oncology.
[77] T. Sakurai. Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. , 2006, CNS & neurological disorders drug targets.
[78] J. Sprouse. Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics , 2004, Expert opinion on therapeutic targets.
[79] Mellar P. Davis,et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] Anna Wirz-Justice,et al. Biological rhythm disturbances in mood disorders , 2006, International clinical psychopharmacology.
[81] F. Davis,et al. Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters , 2009, Behavioural Brain Research.
[82] S. Ancoli-Israel,et al. The Effects of Standard Anthracycline-Based Chemotherapy on Soluble ICAM-1 and Vascular Endothelial Growth Factor Levels in Breast Cancer , 2004, Clinical Cancer Research.
[83] L. Nail,et al. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. , 2006, Oncology nursing forum.
[84] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[85] V. Perry,et al. Identification and treatment of symptoms associated with inflammation in medically ill patients , 2008, Psychoneuroendocrinology.
[86] F. Lévi,et al. Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status , 2002, Chronobiology international.
[87] S. Reppert,et al. Coordination of circadian timing in mammals , 2002, Nature.
[88] R. Dantzer,et al. Cytokine-induced sickness behavior , 2003, Brain, Behavior, and Immunity.
[89] R. Dantzer,et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? , 2003, Cancer.
[90] I. Bosaeus,et al. Daily Physical-Rest Activities in Relation to Nutritional State, Metabolism, and Quality of Life in Cancer Patients with Progressive Cachexia , 2007, Clinical Cancer Research.
[91] M. Ramoni,et al. Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy , 2008, Cancer.
[92] N. Douglas,et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[93] F. Lévi,et al. Non‐invasive estimation of the circadian rhythm in serum cortisol in patients with ovarian or colorectal cancer , 1998, International journal of cancer.
[94] S. Ancoli-Israel,et al. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer , 2008, Brain, Behavior, and Immunity.
[95] L. Tulman,et al. Symptom Clusters: Concept Analysis and Clinical Implications for Cancer Nursing , 2005, Cancer nursing.
[96] F. Lévi,et al. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. , 2007, Cold Spring Harbor symposia on quantitative biology.
[97] Andrew N. Coogan,et al. Neuroimmunology of the circadian clock , 2008, Brain Research.
[98] I. Tannock,et al. Cytokines and their relationship to the symptoms and outcome of cancer , 2008, Nature Reviews Cancer.
[99] S. Iacobelli,et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. , 2009, Cancer research.
[100] S. Kay,et al. Mammalian circadian signaling networks and therapeutic targets. , 2007, Nature chemical biology.
[101] L. Sarna,et al. Physical activity and fatigue during radiation therapy: a pilot study using actigraph monitors. , 2001, Oncology nursing forum.
[102] P. Jean-Pierre,et al. Cancer-related fatigue: the scale of the problem. , 2007, The oncologist.
[103] C. Weitz,et al. Regulation of Daily Locomotor Activity and Sleep by Hypothalamic EGF Receptor Signaling , 2001, Science.